Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Invictus MD Strategies Corp IVITF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.


GREY:IVITF - Post by User

Invictus MD Strategies Corp > News
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(16)
•••
Comment by display_nameon Mar 08, 2019 6:10pm
118 Views
Post# 29463863

RE:RE:RE:News

RE:RE:RE:NewsProbably a net benefit? Idk without revised conditions being stated it's tough to say but I'd expect them not spending 42 mil to be a positive? I'd like to hear what is happening to the incentive goals whuh were laid put for Z3 on the assumption of partial ownership by the JV partner's. Im hoping those are being scrapped in favor of some more straightforward cost and revenue sharing JV structure. At any rate it feels like we've found the bottom, second day in a row that .91 support level has held up. Expecting some sideways consolidation and a pump.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities